EUropean Pharmacogenetics of AntiCoagulant Therapy - Phenprocoumon

PHASE4CompletedINTERVENTIONAL
Enrollment

970

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

January 31, 2013

Study Completion Date

April 30, 2013

Conditions
Venous Thromboembolism (VTE)Atrial Fibrillation (AF)
Interventions
OTHER

Genotype-guided dosing algorithm

Loading and monitoring dose according to genotype-guided dosing algorithm

OTHER

Non-genotype-guided dosing algorithm

Loading and monitoring dose according to non-genotype-guided dosing algorithm

Trial Locations (3)

Unknown

Elisabethinen Hospital Linz, Linz

University of Ulm, Ulm

Utrecht University, Utrecht

Sponsors

Collaborators (1)

All Listed Sponsors
lead

Utrecht Institute for Pharmaceutical Sciences

OTHER

collaborator

Utrecht University

OTHER

collaborator

Leiden University Medical Center

OTHER

collaborator

Erasmus Medical Center

OTHER

collaborator

University of Ulm

OTHER

collaborator

Newcastle University

OTHER

collaborator

University of Liverpool

OTHER

collaborator

LGC Limited

INDUSTRY

collaborator

Uppsala University

OTHER

collaborator

Democritus University of Thrace

OTHER

collaborator

Elisabethinen Hospital

OTHER

NCT01119274 - EUropean Pharmacogenetics of AntiCoagulant Therapy - Phenprocoumon | Biotech Hunter | Biotech Hunter